An interventional study of Surgeon-administered Transversus Abdominis Plane Block 0.25% bupivicaine 0.25 mL/kg in Cesarean Section Complications and Pain, Postoperative, sponsored by University of Calgary. Recruiting at 1 site in Canada. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-15.
Sponsored by University of Calgary · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 190 studies in Pain, Postoperative with a site in Canada — 38 open to participants now, 42 under way, 3 of them phase 3. Pain, Postoperative · Canada.
Among the 190 studies in Pain, Postoperative with a site in Canada, this one is the 92nd largest by planned enrollment of the 175 interventional ones that give a count, is one of 12 that started in 2025, is one of 94 with no phase, reaches primary completion later than 22 of the 41 other live ones, and was the 169th registered.
5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.
Browse Pain, Postoperative studies →38 of the 190 studies in Pain, Postoperative with a site in Canada are open now. Recruiting first, the newest first:
Université de Sherbrooke · Sites in Canada
Ages 18+
Mount Sinai Hospital, Canada · Sites in Canada
Ages 18+ · Women only · Healthy volunteers
Mount Sinai Hospital, Canada · Sites in Canada
Ages 18+ · Women only · Healthy volunteers
Université de Sherbrooke · Sites in Canada
Ages 18+
Unity Health Toronto · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.
This study: 18 Years and older · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
190 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 8 · Phase 2 17 · Phase 3 22 · Phase 4 38
First in 2004; this study’s year is marked. 12 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is close to the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.
Median enrollment 82 across the 175 interventional studies, 140 across the 15 observational. Of the 125 that completed or were terminated, 8 (6%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 190 have an industry lead sponsor. The 10 most frequent:
University of Calgary is the lead sponsor of 704 studies on the registry; 197 are open to participants now.
Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.
University of Calgary has 6 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
13 of the studies in Pain, Postoperative with a site in Canada that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07434310Phase 3Dr. Naveed SiddiquiUse of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults | 2027-07-01 |
| NCT06324942University of CalgaryAnalgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section. | 2026-12 |
| NCT06276257CHU de Quebec-Universite LavalParavertebral Block for Mastectomy With Immediate Reconstruction | 2026-12 |
| NCT03675386University Health Network, TorontoReducing Opioid Use for Chronic Pain Patients Following Surgery | 2026-12-31 |
| NCT05722002University of MichiganComparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial | 2027-02-10 |
Add all 13 to your calendar (.ics) → With an account.
Among the 190 studies in Pain, Postoperative with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this research study is to evaluate whether or not adding a Transversus Abdominis Plane Block (TAP block) improves pain control for patients having a cesarean section. A TAP block is a type of nerve block where at the end of the surgery an injection of a long acting local anesthetic is made into the abdominal wall. In studies in patient's having other abdominal surgeries this has reduced the amount of narcotics patients need for pain control. This may also led to patients being more active after surgery and maybe spending less time in hospital.
Randomized clinical trial of Transversus Abdominis Plane Block (TAP block) at Cesarean Section.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
After uterine closure, the anterior abdominal wall on the contralateral side to the surgeon is elevated and retracted laterally by an assistant. The bowel and uterus is retracted using the surgeon's non-dominant hand, with or without a sponge. Under direct visualization, a blunted spinal needle is inserted lateral to the rectus muscle to avoid injury to inferior epigastric blood vessels. The needle is then gently advanced through the transversus abdominis fascia into the TAP plane, identified at loss of resistance, or 'a pop'. After aspiration to confirm no accidental placement of the needle intravascularly, local anaesthetic is infiltrated into the transverse abdominis plane through the parietal peritoneum by the surgeon at a prespecified dose of 0.25% bupivicaine 0.25 mL/kg (approximately 20cc). This is repeated on the contralateral side, after which closure of the fascia, subcutaneous tissue, and skin were performed.
Other: Surgeon-administered Transversus Abdominis Plane Block 0.25% bupivicaine 0.25 mL/kg
A sham procedure will not be performed but the patient will be unaware of whether or not an injection was done.
Surgeon-administered Transversus Abdominis Plane Block
Also known as: TAP block
Post operative Pain
VAS scale 0-no pain to 10-worst pain
Time frame: 12 hours post op
Time to first request for rescue analgesia in hours
Time from completion of surgery to first request for rescue analgesia in hours
Time frame: 48 hours post op
Post operative Opioid use
Total opioid consumption in the first 24h and 48h mark, postoperatively
Time frame: up to 48 hours post op.
Time from surgery to discharge from hospital
Time from completion of surgery to discharge
Time frame: Up to discharge from hospital, usually 1-3 days
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Feb 2025 (actual). Primary completion is estimated for Dec 2026, 22 months after the start.
Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 22 months is above that.
Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.